| Quinolone resistance from a transferable plasmid L Martínez-Martínez, A Pascual, GA Jacoby The Lancet 351 (9105), 797-799, 1998 | 1666 | 1998 |
| Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. SR Mehta, S Yusuf, R Díaz, J Zhu, P Pais, D Xavier, E Paolasso, R Ahmed, ... Jama 293 (4), 437-446, 2005 | 894 | 2005 |
| Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae J Rodríguez-Baño, B Gutiérrez-Gutiérrez, I Machuca, A Pascual Clinical microbiology reviews 31 (2), 10.1128/cmr. 00079-17, 2018 | 737 | 2018 |
| Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients J Rodríguez-Bano, MD Navarro, L Romero, L Martínez-Martínez, ... Journal of clinical microbiology 42 (3), 1089-1094, 2004 | 707 | 2004 |
| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 681 | 2009 |
| Global dissemination of a multidrug resistant Escherichia coli clone NK Petty, NL Ben Zakour, M Stanton-Cook, E Skippington, M Totsika, ... Proceedings of the National Academy of Sciences 111 (15), 5694-5699, 2014 | 618 | 2014 |
| Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 569 | 2008 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 489 | 2017 |
| Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Peña, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 461 | 2010 |
| Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of … F Fernández-Cuenca, L Martínez-Martínez, MC Conejo, JA Ayala, ... Journal of Antimicrobial Chemotherapy 51 (3), 565-574, 2003 | 434 | 2003 |
| Plasmid-mediated quinolone resistance: an update JM Rodríguez-Martínez, ME Cano, C Velasco, L Martínez-Martínez, ... Journal of Infection and Chemotherapy 17, 149-182, 2011 | 406 | 2011 |
| Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge J Rodríguez-Baño, MD Navarro, L Romero, MA Muniain, M Cueto, ... Clinical infectious diseases 43 (11), 1407-1414, 2006 | 389 | 2006 |
| Roles of β-Lactamases and Porins in Activities of Carbapenems and Cephalosporins against Klebsiella pneumoniae L Martínez-Martínez, A Pascual, S Hernández-Allés, D Alvarez-Díaz, ... Antimicrobial agents and chemotherapy 43 (7), 1669-1673, 1999 | 364 | 1999 |
| β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc … J Rodriguez-Bano, MD Navarro, P Retamar, E Picon, A Pascual, ... Clinical Infectious Diseases 54 (2), 167-174, 2012 | 359 | 2012 |
| Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 350 | 2008 |
| Redefining extended-spectrum β-lactamases: balancing science and clinical need CG Giske, AS Sundsfjord, G Kahlmeter, N Woodford, P Nordmann, ... Journal of Antimicrobial Chemotherapy 63 (1), 1-4, 2009 | 316* | 2009 |
| Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology J Rodriguez-Bano, L Lopez-Cerero, MD Navarro, PD de Alba, A Pascual Journal of antimicrobial chemotherapy 62 (5), 1142-1149, 2008 | 302 | 2008 |
| Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 259 | 2019 |
| Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases in Spain JR Hernández, L Martínez-Martínez, R Cantón, TM Coque, A Pascual Antimicrobial agents and chemotherapy 49 (5), 2122-2125, 2005 | 258 | 2005 |
| Impact of an Evidence-Based Bundle Intervention in the Quality-of-Care Management and Outcome of Staphylococcus aureus Bacteremia LE López-Cortés, MD Del Toro, J Gálvez-Acebal, ... Clinical Infectious Diseases 57 (9), 1225-1233, 2013 | 248 | 2013 |
